Accel Partners
+23.57%
3个月收益率
$43.100
-0.427 (-0.99%)收盘时
Ethos Technologies Inc. is a United States-based life insurance company. The Company offers whole life insurance and term life insurance. Its whole life insurance provides accidental death benefit and death benefit. Its term life insurance offers monthly payment of premiums that do not increase during the term. It is provided for age 65-85 years. Its term life insurance provides coverage for a term typically 10-30 years. The Company operates in every United States and the District of Columbia.
Ethos Technologies Inc. is a good buy right now due to its strong financial performance, including a 113.8% year-over-year revenue growth in Q2 2026, reaching $190 million, and a gross margin of 97.06%. Additionally, the stock has an RSI of 72, indicating strong momentum. The main risk is the negative net income reported in Q1 2026, which was -172 million USD, but the company has shown recovery in Q2 with a net income of 19.53 million USD.

Ethos Technologies to Release Q3 2026 Financial Results

Ethos Signs Erin Andrews as Brand Ambassador

aTyr Pharma Presents Significant Advancements in Efzofitimod Research

Ethos Technologies Reports Strong Q2 Results, Shares Surge 24%

Ethos Technologies Reports Exceptional Q2 2026 Earnings Growth
Ethos Technologies Inc. is a United States-based life insurance company. The Company offers whole life insurance and term life insurance. Its whole life insurance provides accidental death benefit and death benefit. Its term life insurance offers monthly payment of premiums that do not increase during the term. It is provided for age 65-85 years. Its term life insurance provides coverage for a term typically 10-30 years. The Company operates in every United States and the District of Columbia. It operates in the Financials sector (BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) industry).
Ethos Technologies Inc. is a good buy right now due to its strong financial performance, including a 113.8% year-over-year revenue growth in Q2 2026, reaching $190 million, and a gross margin of 97.06%. Additionally, the stock has an RSI of 72, indicating strong momentum. The main risk is the negative net income reported in Q1 2026, which was -172 million USD, but the company has shown recovery in Q2 with a net income of 19.53 million USD.
暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。